pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 322 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    DASATINIB
    DASATINIB
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Xspray Pharma AB2 cat
  • Marketed
    LENALIDOMIDE
    LENALIDOMIDE
    Follicular Lymphoma Bristol-Myers Squibb Co2 cat
  • Marketed
    NELARABINE
    NELARABINE
    no indication$AMRX Amneal Pharmaceuticals, Inc.2 cat
  • Marketed
← prev
page 4 of 11
next →
131
Pain89
Neurology1
Onureg
Onureg (azacitidine)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Bristol-Myers Squibb Co
2 cat
  • Marketed
    TOREMIFENE CITRATE
    TOREMIFENE CITRATE
    Metastatic Breast Cancer Rising Pharma Holdings Inc2 cat
  • Marketed
    cosibelimab
    Unloxcyt (cosibelimab-ipdl)
    Cutaneous Squamous Cell Carcinoma (cSCC) Checkpoint Therapeutics Inc2 cat
  • Marketed
    denosumab biosimilar
    Jubereq (denosumab-dssb)
    Post Menopausal Osteoporosis Luye Pharma Group Ltd2 cat
  • Marketed
    imetelstat sodium
    Rytelo (imetelstat sodium)
    Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)$GERN GERON CORP2 cat
  • Marketed
    ipilimumab
    Yervoy (ipilimumab)
    Esophageal Squamous Cell Carcinoma (ESCC) Bristol-Myers Squibb Co2 cat
  • Marketed
    lenvatinib mesylate
    Lenvima (lenvatinib mesylate)
    Renal Cell Carcinoma Eisai Co Ltd2 cat
  • Marketed
    revumenib citrate
    Revuforj (revumenib citrate)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$SNDX Syndax Pharmaceuticals Inc2 cat
  • Marketed
    tarlatamab
    Imdelltra (tarlatamab-dlle)
    Small-Cell Lung Cancer$AMGN AMGEN INC2 cat
  • Marketed
    zongertinib
    Hernexeos (zongertinib)
    Non-Small Cell Lung Cancer Boehringer Ingelheim Corp2 cat
  • Marketed
    Bortezomib Pfizer
    Bortezomib
    Mantle Cell Lymphoma Hospira Inc1 cat
  • Marketed
    CLADRIBINE
    CLADRIBINE
    Relapsing Remitting Multiple Sclerosis (RRMS) EMD Serono Inc1 cat
  • Marketed
    DECITABINE
    DECITABINE
    Chronic Myelomonocytic Leukemia (CMML) Mylan Institutional Inc1 cat
  • Marketed
    HYDROCORTISONE SODIUM SUCCINATE
    HYDROCORTISONE SODIUM SUCCINATE
    Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti… Cipla USA Inc1 cat
  • Marketed
    IDELALISIB
    IDELALISIB
    Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)$GILD GILEAD SCIENCES, INC.1 cat
  • Marketed
    Jelmyto
    Jelmyto (mitomycin)
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma)$URGN UroGen Pharma Ltd.1 cat
  • Marketed
    LOMUSTINE
    LOMUSTINE
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Carnegie Pharmaceuticals LLC1 cat
  • Marketed
    NILOTINIB
    NILOTINIB
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Xspray Pharma AB1 cat
  • Marketed
    avelumab
    Bavencio (avelumab)
    Merkel Cell Carcinoma EMD Serono Inc1 cat
  • Marketed
    axitinib SR
    AXPAXLI (axitinib)
    Wet (Neovascular / Exudative) Macular Degeneration$OCUL OCULAR THERAPEUTIX, INC1 cat
  • Marketed
    belantamab mafodotin
    Blenrep (belantamab mafodotin-blmf)
    Refractory Multiple Myeloma GlaxoSmithKline LLC1 cat
  • Marketed
    busulfan
    Myleran (busulfan)
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Woodward Pharma Services LLC1 cat
  • Marketed
    ceritinib
    Zykadia (ceritinib)
    Non-Small Cell Lung Cancer$NVS NOVARTIS AG1 cat
  • Marketed
    denosumab
    Prolia (denosumab)
    Glucocorticoid-Induced Osteoporosis$AMGN AMGEN INC1 cat
  • Marketed
    eflornithine hydrochloride
    Iwilfin (eflornithine hydrochloride)
    Neuroblastoma US WorldMeds LLC1 cat
  • Marketed
    etoposide
    Etopophos (etoposide)
    Small-Cell Lung Cancer H2-Pharma LLC1 cat
  • Marketed
    fruquintinib
    Fruzaqla (fruquintinib)
    Metastatic Colorectal Cancer Takeda Pharmaceuticals USA Inc1 cat